Dr. Li is a member of the Translational Therapeutics Program at the OSUCCC – James and the founding director of the Institute for Immuno-Oncology (IIO), which is dedicated to transforming the OSUCCC – James into a leader in basic and clinical immunology research, including prevention and survivorship.
Ephraim Ansa-Addo, PhD
Dr. Ansa-Addo specializes in regulatory T cells.
Kenneth Oestreich, PhD
Dr. Oestreich focuses on follicular helper T cells.
Immune Monitoring and Discovery
Lynn O'Donnell, PhD
Dr. O'Donnell is an associate professor of Internal Medicine. Her research interests novel cellular therapies for malignancies and regenerative medicine, translational development, GMP manufacturing, and IND and IDE submissions for FDA.
Dr. Das's research focuses on uncovering mechanisms underlying innate and adaptive responses in higher organisms using computational and mathematical tools rooted in statistical physics and engineering.